Search filters

List of works by Werner Hacke

Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial

scientific article

Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

scientific article published in July 2011

Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trial

scientific article published in 2022

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

scientific article

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Em

scientific article

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial F

article by Sameer Bansilal et al published October 2015 in American Heart Journal

Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial

scientific article published on 13 April 2017

GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke

scientific article published on 22 July 2020

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

scientific article

Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data

article

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial

scientific article

International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries

scientific article published on 24 August 2017

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban

article

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial

scientific article

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

scientific article published on 17 February 2016

Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial

scientific article published on 14 March 2013

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Preven

scientific article published on February 2013

Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention o

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin

scientific article published on 03 December 2012

Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Fac

article by Jonathan P Piccini et al published 10 September 2013 in Circulation

Smoking, clopidogrel, and mortality in patients with established cardiovascular disease

scientific article

Standards of Practice in Acute Ischemic Stroke Intervention: International Recommendations

scientific article published on 01 November 2018

Standards of practice in acute ischemic stroke intervention: International recommendations: This article was first published in JNIS. Cite this article as: Pierot L, Jayaraman MV, Szikora I, et al. Standards of practice in acute ischemic stroke inter

scientific article published on 23 October 2018

Standards of practice in acute ischemic stroke intervention: international recommendations

scientific article published on 28 August 2018

Stroke: working toward a prioritized world agenda

scientific article (publication date: June 2010)

Stroke: working toward a prioritized world agenda

scientific article (publication date: 2010)

The Impact of Conscious Sedation versus General Anesthesia for Stroke Thrombectomy on the Predictive Value of Collateral Status: A Post Hoc Analysis of the SIESTA Trial.

scientific article published on 08 June 2017

The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study

article

Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr

scientific article

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial

scientific article

Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial

scientific article published on 22 June 2016